Bovie laparoscopic SEER device approved
Bovie Medical Corp has received clearance to sell a device that cuts and reseals tissue in kidney surgeries. The FDA has approved market of Bovie’s laparoscopic SEER device, which is used for cutting and coagulating soft tissue. It is intended to be used in partial removal of kidneys. Bovie said the laparoscopic SEER, or Saline Enhance Electrosurgical Resection, device is an extension a line the company launched earlier this year.
-
FDA Clears Marketing of PatchAssist Laparoscopic Hernia Mesh Placement Device
BOSS submitted for the FDA approval
NiTi Surgical Solutions Introduces Investigational Bowel Anastomosis Device
Shipment of Alaris infusion pumps resumed
Virtual Ports EndoGrab device receives CE Mark
